- Home
- ELAN vs IVZ Comparison
ELAN vs IVZ Comparison
Compare ELAN & IVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELAN | IVZ |
|---|---|---|
| Founded | 1954 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 13.9B |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ELAN | IVZ |
|---|---|---|
| Price | $22.57 | $29.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 15 |
| Target Price | $31.00 | ★ $34.61 |
| AVG Volume (30 Days) | ★ 4.3M | 4.2M |
| Earning Date | 11-06-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 2.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.22 | ★ 1.27 |
| Revenue | $4,715,000,000.00 | ★ $5,314,100,000.00 |
| Revenue This Year | $8.66 | N/A |
| Revenue Next Year | $5.29 | $8.98 |
| P/E Ratio | $104.30 | ★ $23.27 |
| Revenue Growth | ★ 6.22 | 2.98 |
| 52 Week Low | $19.40 | $20.67 |
| 52 Week High | $27.98 | $33.66 |
Technical Indicators
Market Signals| Indicator | ELAN | IVZ |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 34.01 |
| Support Level | $21.73 | $25.12 |
| Resistance Level | $25.21 | $29.71 |
| Average True Range (ATR) | 0.66 | 0.63 |
| MACD | 0.10 | -0.10 |
| Stochastic Oscillator | 54.11 | 9.56 |
Price Performance
Historical ComparisonAbout ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
About IVZ Invesco Ltd
Invesco provides investment management services to retail (69% of managed assets) and institutional (31%) clients. At the end of May 2026, the firm had $2.454 trillion in assets under management spread among its equity (61% of AUM), balanced (3%), fixed-income (21%), alternative investment (6%), and money market (9%) operations. Passive products account for close to half of Invesco's total AUM. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 32% of its AUM sourced from Europe, Africa, and the Middle East (17%) and Asia (15%).